$590 Million is the total value of BROADWOOD CAPITAL INC's 9 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MNST | Buy | MONSTER BEVERAGE CORP NEW | $212,717,000 | -9.4% | 4,797,408 | +200.0% | 36.06% | -10.2% |
| STAA | STAAR SURGICAL CO | $117,779,000 | +15.4% | 10,855,179 | 0.0% | 19.97% | +14.4% | |
| BTX | BIOTIME INC | $89,878,000 | -7.4% | 24,897,032 | 0.0% | 15.24% | -8.3% | |
| CYNO | Buy | CYNOSURE INCcl a | $61,051,000 | +30.7% | 1,338,827 | +46.0% | 10.35% | +29.5% |
| IWM | ISHARES TRrussell 2000 etf | $56,637,000 | +8.6% | 420,000 | 0.0% | 9.60% | +7.6% | |
| OCX | ONCOCYTE CORPORATION | $18,553,000 | +39.9% | 2,631,680 | 0.0% | 3.14% | +38.5% | |
| AST | ASTERIAS BIOTHERAPEUTICS INC | $17,019,000 | +8.5% | 3,699,848 | 0.0% | 2.88% | +7.5% | |
| MNKKQ | MALLINCKRODT PUB LTD CO | $16,063,000 | -28.6% | 322,411 | 0.0% | 2.72% | -29.3% | |
| ASTWS | ASTERIAS BIOTHERAPEUTICS INC*w exp 02/15/201 | $179,000 | +4.7% | 328,205 | 0.0% | 0.03% | +3.4% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STAAR SURGICAL CO | 42 | Q3 2023 | 59.1% |
| MONSTER BEVERAGE CORP NEW | 34 | Q3 2023 | 49.7% |
| ISHARES TR | 33 | Q3 2023 | 14.8% |
| ONCOCYTE CORPORATION | 31 | Q2 2023 | 4.6% |
| BIOTIME INC | 25 | Q2 2019 | 17.8% |
| AXON ENTERPRISE INC | 24 | Q3 2023 | 13.4% |
| AGEX THERAPEUTICS INC | 20 | Q3 2023 | 1.5% |
| LINEAGE CELL THERAPEUTICS INC | 17 | Q3 2023 | 5.1% |
| ASTERIAS BIOTHERAPEUTICS INC | 16 | Q4 2018 | 2.9% |
| CYNOSURE INC | 15 | Q4 2016 | 10.4% |
View BROADWOOD CAPITAL INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-15 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 4 | 2024-01-10 |
| 4 | 2024-01-05 |
| 4 | 2023-11-30 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-11-14 |
| 4 | 2023-11-09 |
| 4 | 2023-11-06 |
View BROADWOOD CAPITAL INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.